tradingkey.logo
tradingkey.logo
Search

Black Diamond Therapeutics Inc

BDTX
Add to Watchlist
1.690USD
-0.025-1.46%
Close 07-31 16:00ETQuotes delayed by 15 min
96.84MMarket Cap
LossP/E TTM

BDTX Financials

See Black Diamond Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Black Diamond Therapeutics Inc Earnings Date

Latest Release
May 7, 2026
EPS / Forecast
-0.16/-0.18
Revenue / Forecast
0.00/0.00
Period
FY2025 Earnings
Revenue(YoY)
70.00M
--
EPS(YoY)
0.39
131.06%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-115.82%-0.16
6.19%-0.26
45.78%-0.15
48.49%-0.19
383.67%1.00
24.77%-0.28
39.04%-0.28
31.18%-0.36
38.52%-0.35
35.21%-0.38
---0.45
---0.52
---0.57
---0.58
---1.93
----
----
----
----
----
Revenue
-100.00%0.00
--0.00
--0.00
--0.00
--70.00M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net Profit
-115.98%-9.04M
5.44%-15.12M
45.38%-8.50M
46.95%-10.56M
410.24%56.54M
17.64%-15.98M
32.38%-15.56M
-3.95%-19.91M
12.69%-18.23M
7.92%-19.41M
-6.25%-23.01M
16.48%-19.15M
18.16%-20.88M
18.51%-21.08M
38.27%-21.65M
33.25%-22.93M
15.82%-25.51M
-14.32%-25.87M
-95.83%-35.08M
-135.75%-34.35M
Net Margin
----
----
----
----
--80.77%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
----
----
----
----
--100.00%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
-100.00%0.00
--0.00
--0.00
--0.00
--70.00M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
-120.65%-11.26M
43.85%-10.26M
39.45%-10.98M
39.36%-13.42M
369.34%54.53M
12.37%-18.27M
24.50%-18.13M
-10.47%-22.13M
6.10%-20.25M
4.56%-20.86M
-8.53%-24.01M
13.55%-20.03M
16.04%-21.56M
16.21%-21.85M
37.44%-22.12M
33.25%-23.17M
16.39%-25.68M
-12.50%-26.08M
-91.36%-35.36M
-131.00%-34.72M
Net Profit
-115.98%-9.04M
5.44%-15.12M
45.38%-8.50M
46.95%-10.56M
410.24%56.54M
17.64%-15.98M
32.38%-15.56M
-3.95%-19.91M
12.69%-18.23M
7.92%-19.41M
-6.25%-23.01M
16.48%-19.15M
18.16%-20.88M
18.51%-21.08M
38.27%-21.65M
33.25%-22.93M
15.82%-25.51M
-14.32%-25.87M
-95.83%-35.08M
-135.75%-34.35M
Current assets
-21.01%122.97M
30.90%132.44M
20.30%138.99M
15.76%146.73M
31.04%155.68M
-24.51%101.18M
-21.43%115.54M
36.31%126.75M
10.03%118.81M
4.96%134.03M
-2.60%147.05M
-44.83%92.99M
-42.66%107.98M
-40.80%127.71M
-37.50%150.98M
-37.79%168.56M
-36.67%188.30M
-32.50%215.70M
-28.20%241.55M
30.11%270.95M
Total current liabilities
-13.73%14.53M
-23.54%15.73M
-25.26%15.54M
-8.86%16.80M
-0.04%16.85M
4.72%20.57M
38.06%20.80M
32.67%18.44M
31.19%16.85M
28.73%19.65M
-28.74%15.07M
-29.47%13.90M
-34.01%12.85M
-35.45%15.26M
-19.79%21.14M
-16.09%19.71M
4.09%19.47M
66.28%23.64M
132.44%26.36M
282.57%23.49M
Total assets
-24.58%132.92M
16.61%143.01M
14.39%157.73M
10.93%166.38M
23.66%176.25M
-22.66%122.64M
-20.01%137.90M
25.11%149.99M
5.12%142.52M
1.48%158.57M
-4.45%172.38M
-39.71%119.88M
-38.23%135.58M
-36.91%156.25M
-34.19%180.42M
-30.93%198.83M
-29.94%219.48M
-24.87%247.68M
-20.87%274.13M
-17.62%287.88M
Total liabilities
-17.58%28.62M
-21.74%30.80M
-21.96%31.58M
-13.32%33.77M
-9.12%34.73M
-5.92%39.35M
6.32%40.47M
3.41%38.97M
2.20%38.22M
3.13%41.83M
-19.33%38.06M
-18.90%37.68M
-20.31%37.39M
-21.67%40.56M
-14.49%47.19M
26.05%46.46M
44.35%46.92M
136.32%51.78M
189.04%55.18M
482.80%36.86M
Total equity
-26.30%104.30M
34.73%112.21M
29.48%126.15M
19.45%132.61M
35.67%141.52M
-28.66%83.28M
-27.47%97.43M
35.06%111.02M
6.23%104.31M
0.90%116.74M
0.82%134.32M
-46.05%82.20M
-43.10%98.19M
-40.94%115.69M
-39.15%133.23M
-39.30%152.37M
-38.54%172.56M
-36.35%195.90M
-33.11%218.95M
-26.84%251.02M
Net operating income
-119.16%-10.23M
54.92%-6.79M
30.67%-7.85M
37.80%-9.16M
351.95%53.41M
-7.87%-15.05M
38.33%-11.32M
-2.49%-14.73M
-5.83%-21.20M
36.39%-13.96M
-11.45%-18.36M
20.47%-14.37M
29.96%-20.03M
8.76%-21.94M
37.78%-16.48M
28.21%-18.07M
-16.95%-28.60M
-52.44%-24.05M
-130.56%-26.48M
-85.49%-25.16M
Net investment
128.15%19.50M
-110.40%-2.89M
291.70%8.59M
-8093.65%-59.15M
162.23%8.55M
126.70%27.77M
105.79%2.19M
-95.69%740.00K
-155.37%-13.73M
427.52%12.25M
-361.14%-37.88M
-13.29%17.18M
48.28%24.81M
-94.63%2.32M
-59.36%14.51M
-58.90%19.81M
381.55%16.73M
750.45%43.24M
676.53%35.70M
117.24%48.20M
Net financing
-678.13%-185.00K
-167.35%-196.00K
153.17%134.00K
-100.54%-116.00K
-99.23%32.00K
732.61%291.00K
-100.35%-252.00K
--21.38M
7998.04%4.13M
-64.29%-46.00K
138221.15%71.93M
--0.00
-66.67%51.00K
---28.00K
-18.75%52.00K
-100.00%0.00
-68.19%153.00K
-100.00%0.00
-76.30%64.00K
--184.00K

FAQs

What is the total revenue of Black Diamond Therapeutics Inc?

According to Black Diamond Therapeutics Inc's FY2025 earnings report, its total revenue reached 70.00M, with a year-on-year change of 70.00M.

What are the current assets of Black Diamond Therapeutics Inc?

According to Black Diamond Therapeutics Inc's FY2025 earnings report, its current assets were 132.44M, with a year-on-year change of 30.90.

What are the total assets of Black Diamond Therapeutics Inc?

According to Black Diamond Therapeutics Inc's FY2025 earnings report, its total assets of Black Diamond Therapeutics Inc were 143.01M, with a year-on-year change of 16.61.

What are the total liabilities of Black Diamond Therapeutics Inc?

According to Black Diamond Therapeutics Inc's FY2025 earnings report, its total liabilities of Black Diamond Therapeutics Inc were 30.80M, with a year-on-year change of -21.74.

What is the total equity of Black Diamond Therapeutics Inc?

According to Black Diamond Therapeutics Inc's FY2025 earnings report, its total equity of Black Diamond Therapeutics Inc was 112.21M, with a year-on-year change of 34.73.

What is the net operating income of Black Diamond Therapeutics Inc?

According to Black Diamond Therapeutics Inc's FY2025 earnings report, its net operating income of Black Diamond Therapeutics Inc was 19.87M, with a year-on-year change of 125.22.

What is the net investment of Black Diamond Therapeutics Inc?

According to Black Diamond Therapeutics Inc's FY2025 earnings report, its net investment of Black Diamond Therapeutics Inc was -44.91M, with a year-on-year change of -364.65.

What is the net financing of Black Diamond Therapeutics Inc?

According to Black Diamond Therapeutics Inc's FY2025 earnings report, its net financing of Black Diamond Therapeutics Inc was -146.00K, with a year-on-year change of -100.57.

What is the Earnings Per Share (EPS) of Black Diamond Therapeutics Inc?

According to Black Diamond Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 0.39, with a year-on-year change of 131.06.

What is the net income of Black Diamond Therapeutics Inc?

According to Black Diamond Therapeutics Inc's FY2025 earnings report, its net income was 22.37M, with a year-on-year change of 132.10.

What is the Return on Equity (ROE) of Black Diamond Therapeutics Inc?

According to Black Diamond Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was 22.88, with a year-on-year change of 132.84.

What is the Return on Assets (ROA) of Black Diamond Therapeutics Inc?

According to Black Diamond Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was 16.84, with a year-on-year change of 133.98.

What is the operating profit of Black Diamond Therapeutics Inc?

According to Black Diamond Therapeutics Inc's FY2025 earnings report, its operating profit was 19.87M, with a year-on-year change of 125.22.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.